These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29854821)

  • 1. Early Growth Response 1 (Egr1) Is a Transcriptional Activator of NOX4 in Oxidative Stress of Diabetic Kidney Disease.
    Hu F; Xue M; Li Y; Jia YJ; Zheng ZJ; Yang YL; Guan MP; Sun L; Xue YM
    J Diabetes Res; 2018; 2018():3405695. PubMed ID: 29854821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGR1/NOX4 pathway regulates oxidative stress and further facilitates fibrosis progression in keloids responses to TGF-β1.
    Qin H; Zhang L; Li M; Liu Y; Sun S; Nie W; Bai B; Li G; Zhang G
    J Dermatol Sci; 2022 Dec; 108(3):138-145. PubMed ID: 36608994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
    Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
    Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
    Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
    Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease.
    Shi Q; Lee DY; Féliers D; Abboud HE; Bhat MA; Gorin Y
    Mol Metab; 2020 Jun; 36():100968. PubMed ID: 32240965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
    Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression.
    Zhou B; Mu J; Gong Y; Lu C; Zhao Y; He T; Qin Z
    Redox Biol; 2017 Apr; 11():390-402. PubMed ID: 28063381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells.
    Wang D; Guan MP; Zheng ZJ; Li WQ; Lyv FP; Pang RY; Xue YM
    Cell Physiol Biochem; 2015; 36(6):2093-107. PubMed ID: 26279418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH oxidase 4 mediates TGF-β1/Smad signaling pathway induced acute kidney injury in hypoxia.
    Cho S; Yu SL; Kang J; Jeong BY; Lee HY; Park CG; Yu YB; Jin DC; Hwang WM; Yun SR; Song HS; Park MH; Yoon SH
    PLoS One; 2019; 14(7):e0219483. PubMed ID: 31318905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.
    He T; Xiong J; Nie L; Yu Y; Guan X; Xu X; Xiao T; Yang K; Liu L; Zhang D; Huang Y; Zhang J; Wang J; Sharma K; Zhao J
    J Mol Med (Berl); 2016 Dec; 94(12):1359-1371. PubMed ID: 27488452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
    Thallas-Bonke V; Tan SM; Lindblom RS; Snelson M; Granata C; Jha JC; Sourris KC; Laskowski A; Watson A; Tauc M; Rubera I; Zheng G; Shah AM; Harris DCH; Elbatreek MH; Kantharidis P; Cooper ME; Jandeleit-Dahm K; Coughlan MT
    Nephrol Dial Transplant; 2021 May; 36(6):988-997. PubMed ID: 33367789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms.
    Qiao X; Wang L; Wang Y; Su X; Qi Y; Fan Y; Peng Z
    Ren Fail; 2017 Nov; 39(1):652-659. PubMed ID: 28805491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
    Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
    Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway.
    Chen ZQ; Sun XH; Li XJ; Xu ZC; Yang Y; Lin ZY; Xiao HM; Zhang M; Quan SJ; Huang HQ
    Acta Pharmacol Sin; 2020 Dec; 41(12):1587-1596. PubMed ID: 32724174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).
    Yu D; Yang X; Zhu Y; Xu F; Zhang H; Qiu Z
    Endocr J; 2021 May; 68(5):519-529. PubMed ID: 33408314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early growth response protein-1 upregulates long noncoding RNA Arid2-IR to promote extracellular matrix production in diabetic kidney disease.
    Yang YL; Hu F; Xue M; Jia YJ; Zheng ZJ; Li Y; Xue YM
    Am J Physiol Cell Physiol; 2019 Mar; 316(3):C340-C352. PubMed ID: 30462533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48-linked NADPH oxidase 4 polyubiquitination and degradation.
    Chen Z; Sun X; Chen Q; Lan T; Huang K; Xiao H; Lin Z; Yang Y; Liu P; Huang H
    Br J Pharmacol; 2020 Jan; 177(1):145-160. PubMed ID: 31465542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis.
    Li X; Ma TK; Wang P; Shi H; Hai S; Qin Y; Zou Y; Zhu WT; Li HM; Li YN; Yin L; Xu YY; Yang Q; Zhang S; Ding H
    Cell Death Dis; 2024 Jun; 15(6):398. PubMed ID: 38844470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways.
    Jha JC; Dai A; Garzarella J; Charlton A; Urner S; Østergaard JA; Okabe J; Holterman CE; Skene A; Power DA; Ekinci EI; Coughlan MT; Schmidt HHHW; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm K
    Diabetes; 2022 Jun; 71(6):1282-1298. PubMed ID: 35275988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.